Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRYO-CELL (CCEL) -- Ignore unavailable to you. Want to Upgrade?

To: CUBBY who wrote (19)	9/17/1999 1:55:00 PM
From: CUBBY	Read Replies (1) \| Respond to of 53

CRYO-CELL Awarded Patent on CCEL III Variable Capacity Cellular Storage System September 17, 1999 01:14 PM CLEARWATER, Fla., Sept. 17 /PRNewswire/ -- Daniel D. Richard, Chairman, Chief Executive of CRYO-CELL International, Inc., CCEL , announced today that the U.S. Patent Office had granted a patent to the Company on its CCEL III cryogenic cellular storage system. Robert E. Vago, Vice President of Research and Development, invented the CCEL III and has assigned all rights to CRYO-CELL International, Inc. According to Mr. Vago, "This robotically operated computer-controlled unit can take CRYO-CELL well into the 21st century. Each CCEL III installation can commence vial storage with one dewar, one computer and one robot. Each dewar can be factory-configured to contain the same or differing vial types, as required. The storage capacity of each dewar ranges from 17,500 five- milliliter to 1,000,000 one-tenth milliliter vials. Each CCEL III installation can be field-retrofitted to contain up to eight storage dewars; each dewar is served by the same original computer and robot." The Company has been advised that the Mitsubishi robots which were manufactured for CRYO-CELL as part of the CCEL III are an advanced design to the ones used by Eli Lilly Pharmaceuticals, where they have operated 24 hours/day for the past 15 years without failure. The Company's attorneys are filing for patents in 17 European countries, including the United Kingdom, Germany, France, Italy, Ireland, the Benelux countries, plus Canada, Japan and others. CRYO-CELL offers America's most affordable U-Cord(TM) storage program. Expectant parents call 800-STOR-CELL, (800-786-7235), or visit their Web site, www.cryo-cell.com . CRYO-CELL is a publicly traded company. Its common stock trades on The Nasdaq Stock Market(R) under the symbol CCEL. Forward-Looking Statement Statements wherein the terms "believes," "intends," or "expects," as used, are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by the Company. SOURCE CRYO-CELL International, Inc. cubby